#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    High-grade B-cell lymphoma HER2 gene amplification Liposarcoma metastatic Leukocyte adhesion deficiency type I Hidradenitis Gastrointestinal stromal tumour Extra-osseous Ewing's sarcoma recurrent Cystic fibrosis Waldenstrom's macroglobulinaemia recurrent Hepatitis D Depression Chronic inflammatory demyelinating polyradiculoneuropathy Medulloblastoma Follicular lymphoma Hypocalcaemia More trials…

    Learn about Rare Diseases

    Pituitary-dependent Cushing’s syndrome – Life with Disease Tuberous sclerosis complex – Treatment Biotinidase deficiency – Trials in Disease Uterine leiomyosarcoma – Trials in Disease Urea cycle disorder – Basic Information Paroxysmal nocturnal haemoglobinuria – Diagnostics Breast angiosarcoma metastatic – Basic Information Retinoblastoma – Basic Information X-linked lymphoproliferative syndrome – Basic Information Alternating hemiplegia of childhood – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Travoprost Agomelatine Ezetimibe Lenzumestrocel Erenumab AZD0516 Tiotropium Bromide Monohydrate ANHYDROUS CALCIUM FOLINATE Metamizole Magnesium Sunvozertinib Ifezuntirgene Inilparvovec Cendakimab Ademetionine ANTI-GD2-800CW Alemtuzumab Pancreas Powder Colestyramine Water For Injections Mrna-4157 Fluorouracil More therapies…

    Learn about Your Condition

    Gestational diabetes Skin cancer Rhabdoid tumour Pharyngeal cancer stage I Congenital ureteric anomaly Hepatic angiosarcoma Acromegaly Peritoneal sarcoma Genitourinary tract neoplasm Colitis ROHHAD syndrome Arterial disorder Apathy Hyperparathyroidism secondary Hypereosinophilic syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Retinoblastoma Treatment: Evaluating the Effectiveness of Topotecan, Vincristine Sulfate, and Etoposide in Patients Eligible for Conservative Therapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Retinoblastoma
    Investigated Drugs:
    • Melphalan Hydrochloride
    • Topotecan
    • Etoposide
    France

  • Study on the Safety and Effectiveness of Linvoseltamab, Sarilumab, and Dexamethasone in Adults with Relapsed or Refractory AL Amyloidosis

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Primary amyloidosis
    Investigated Drugs:
    • Sarilumab
    • Diphenhydramine Hydrochloride
    • Dexamethasone Sodium Phosphate
    Greece Spain

  • Study on the Safety and Effectiveness of TZ-161 for Adults with Early Acute Spinal Cord Injury

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Eletriptan
    Portugal Spain

  • Evaluation of Bevacizumab in Patients with Brain Radionecrosis After Radiation Treatment for Brain Metastases

    Recruiting

    3 1 1
    Investigated Diseases:
    • Metastases to central nervous system
    Investigated Drugs:
    • Sodium Chloride
    • Prednisolone
    • Bevacizumab
    France

  • Study on the Effectiveness of 2LEBV and 2LXFS for Reducing Fatigue in Patients with Epstein-Barr Virus Infection

    Recruiting

    3 1 1
    Investigated Diseases:
    • Epstein-Barr virus infection
    • Epstein-Barr virus infection reactivation
    Investigated Drugs:
    • Deoxyribonucleic Acid
    • Interferon Alfa
    • Interferon Gamma
    Belgium

  • Study on Darolutamide and Radiation Therapy for Patients with Castration-Resistant Prostate Cancer and Oligometastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Goserelin
    • Triptorelin
    • Darolutamide
    Belgium France Ireland Spain
Previous Page
1 … 495 496 497 498 499 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!